Skip to main content

Profusa, Inc.

corporate_fare Company Profile

Profusa, Inc.

PFSA·NASDAQ·Industrial Applications And Services·CIK 0001859807

Profusa, Inc. is a digital health technology company based in Berkeley, California. Originally incorporated as Northview Acquisition Corp., the company completed a business combination on July 11, 2025, and subsequently changed its name to Profusa, Inc. Over the last twelve years, Profusa has invested more than $100 million from venture investors and U.S. research institutions, including approximately $30 million from the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH). This investment has been used to develop a unique biosensor platform. This platform is designed to be easily injected subcutaneously, providing real-time, individual biochemistry in a cost-effective manner, and functions for more than six times longer than existing best-in-class solutions. Profusa's Lumee™ technology is a platform, not a single product, with the potential to launch products for multiple applications. The company's strategy has involved significant investment in developing and protecting its technology as a private company, initially focusing on Europe due to traditionally lower regulatory barriers compared to the U.S. Profusa has validated its technology and obtained CE approval in the European Union (EU) for its first product, Lumee Oxygen. The company is currently working to meet new Medical Device Regulation (MDR) requirements in Europe. In 2026, Profusa plans to launch Lumee Oxygen in the U.S., pending approval by the U.S. Food and Drug Administration (FDA), for sophisticated wound care management through a distribution partner. The accessible markets for Profusa's technology extend beyond the U.S. and the EU.

Profusa, Inc. (NASDAQ:PFSA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 73 items for PFSA at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Profusa Sets 1-for-4 Reverse Split Effective August 17
  • Profusa Signs Binding Option to Acquire G3 Vision Labs, Potential Change of Control
  • Profusa Converts Term Sheet into Binding Option to Acquire G3 Vision Labs, Issues Equity Consideration, and Targets Nasdaq Compliance
  • Profusa Signs Non-Binding Term Sheet to Acquire $111M-Revenue Diagnostics Company, Overhauls Leadership
  • Profusa Signs Non-Binding Term Sheet to Acquire Commercial-Stage Diagnostics Firm, Reshuffles Management

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$35.82M
Diluted EPS
-$107.01
Op. Cash Flow
-$16.25M
Free Cash Flow
-$16.26M
Operating Income
-$27.71M
Cash & Equivalents
$1.78M
Total Debt
$7.88M
Debt / Equity
-0.30×
Shares Outstanding
1.23M sh
Source: 10-K · filed 2026-04-15 · accession 0001213900-26-044046
$0.3242 +0.25% today
52-week range · as of 2026-11-13 $0.3242 – $1539.75
Market cap
$1.84M
Volume
164.5K (0.1× avg)
3-mo avg 2.1M
Live data · 2026-11-22 12:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PFSA - Filings & News (Page 2)

PFSA
Aug 13, 2026, 8:42 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.8999
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 31, 2026, 5:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.860
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 31, 2026, 4:56 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.870
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 27, 2026, 6:08 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.57
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 27, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.64
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 07, 2026, 8:52 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.088
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 07, 2026, 8:43 AM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.088
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 07, 2026, 8:39 AM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.088
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 07, 2026, 8:37 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.088
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 06, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.1092
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jul 02, 2026, 11:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.1041
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jun 24, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.1128
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jun 23, 2026, 1:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.1702
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jun 08, 2026, 8:19 AM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.2694
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
Jun 08, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.2953
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
May 26, 2026, 12:35 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.3702
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
May 26, 2026, 11:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.370
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
May 26, 2026, 11:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.370
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
May 18, 2026, 7:50 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.451
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
PFSA
May 18, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4341
Real-time Price: $0.3242 info
Change: Reverse Stock Split info
Market Cap: $1.838M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets